The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data.
Rod Discusses US and EU CBD Regulations at Europe Canna Expo-Dublin
For my talk, I compared and contrasted the hemp and CBD regulatory regimes in Europe and US. Although they parallel each other in some respects, particularly policy, they are fundamentally different in their approaches.
The Mouth Swab Drug Test and Employment (Guest Post)
The mouth swab drug test is commonly used by employers. Here’s what you need to know.
The Health Benefits of Cannabis (Guest Post)
Governments across the world, having become familiar with the health benefits of marijuana, are now legalizing cannabis use for medical patients. As a result, medical marijuana has become more mainstream than ever in the health industry.
Enter the Regulators: The FDA Issues A Statement About Hemp and CBD
Although not binding law, the FDA’s Statement provides some important insights into its current view and the direction it may take with respect to hemp and CBD.
Rod Quoted in the Wall Street Journal about Novel Cannabinoids
Research suggests that some cannabinoids may, in fact, increase focus, suppress appetite and keep users awake.
The Rapidly Evolving Legal Status of CBD
To say that all CBD is unlawful because it is a derivative of Cannabis is nonsensical; there are lawful and unlawful types of Cannabis.
Cannabis Intellectual Property- Do Your Products Violate A Patent?
I am not exaggerating when I say that the future of your cannabis business, and the industry at large, may depend on the outcome of this case.
FDA Approves CBD Medication
The FDA approved Epidiolex, a marijuana derived CBD medication manufactured by GW…
Did the Federal Right to Try Act Just Legalize Medical Marijuana?
No. So why am I writing about it? I feel compelled to…